|
EP0037441B1
(en)
*
|
1980-03-10 |
1984-05-09 |
Seiji Arakawa |
Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein
|
|
JPS5835121A
(ja)
*
|
1981-08-20 |
1983-03-01 |
ビラス・ヴィー・リクハイト |
免疫刺激性補助剤からなる抗原及び免疫療法におけるその使用
|
|
US4652522A
(en)
*
|
1983-07-05 |
1987-03-24 |
The University Of Pennsylvania |
Continuous lymphocyte cell lines, their production and use
|
|
JPS6038328A
(ja)
*
|
1983-08-11 |
1985-02-27 |
Handai Biseibutsubiyou Kenkyukai |
抗腫瘍免疫誘導の増強法
|
|
US6338853B1
(en)
|
1987-04-23 |
2002-01-15 |
Jean-Claude Bystryn |
Anti-cancer vaccine
|
|
US5030621A
(en)
*
|
1987-04-23 |
1991-07-09 |
Bystryn Jean Claude |
Shed melanoma antigen compositions
|
|
US5124148A
(en)
*
|
1988-04-27 |
1992-06-23 |
United Cancer Research Institute |
Method for treating viral diseases with attenuated virus
|
|
US5215745A
(en)
*
|
1988-04-27 |
1993-06-01 |
United Cancer Research Institute |
Method for treating viral diseases with attenuated virus
|
|
WO1990011765A1
(en)
*
|
1989-04-11 |
1990-10-18 |
Board Of Regents, The University Of Texas System |
Antitumor preparation obtained following oncolysate treatment
|
|
US7585512B1
(en)
|
1990-05-08 |
2009-09-08 |
Thomas Jefferson University |
Composition and method of using tumor cells
|
|
US5290551A
(en)
*
|
1990-05-08 |
1994-03-01 |
Thomas Jefferson University |
Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
|
|
PT1314431E
(pt)
|
1993-04-30 |
2008-10-24 |
Wellstat Biologics Corp |
Composições purificadas de vírus da doença de newcastle
|
|
US6051227A
(en)
*
|
1995-07-25 |
2000-04-18 |
The Regents Of The University Of California, Office Of Technology Transfer |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
|
|
US6110461A
(en)
|
1997-08-13 |
2000-08-29 |
Oncolytics Biotech Inc. |
Reovirus for the treatment of neoplasia
|
|
US6136307A
(en)
*
|
1997-08-13 |
2000-10-24 |
Oncolytics Biotech Inc. |
Reovirus for the treatment of cellular proliferative disorders
|
|
US6565831B1
(en)
*
|
1999-02-24 |
2003-05-20 |
Oncolytics Biotech Inc. |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
|
|
US7780962B2
(en)
*
|
1997-10-09 |
2010-08-24 |
Wellstat Biologics Corporation |
Treatment of neoplasms with RNA viruses
|
|
US20030044384A1
(en)
*
|
1997-10-09 |
2003-03-06 |
Pro-Virus, Inc. |
Treatment of neoplasms with viruses
|
|
HUP0302278A3
(en)
*
|
1999-04-15 |
2011-01-28 |
Pro Virus |
Treatment of neoplasms with viruses
|
|
US6586411B1
(en)
|
2000-08-16 |
2003-07-01 |
Mayo Foundation For Medical Education And Research |
System for monitoring the location of transgenes
|
|
US6896881B1
(en)
|
1999-09-24 |
2005-05-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
|
US7015205B1
(en)
|
1999-10-18 |
2006-03-21 |
St. Vincent's Hospital And Medical Center Of New York |
Melanoma vaccine and methods of making and using same
|
|
US7118740B1
(en)
*
|
2000-09-22 |
2006-10-10 |
Mayo Foundation For Medical Education And Research |
Method for limiting the growth of cancer cells using an attenuated measles virus
|
|
EP1984007B1
(en)
*
|
2006-02-13 |
2015-08-19 |
Oncolytics Biotech Inc. |
Use of low dose local immune suppression to enhance oncolytic viral therapy
|
|
US9951117B2
(en)
|
2010-09-02 |
2018-04-24 |
Mayo Foundation For Medical Education And Research |
Vesicular stomatitis viruses
|
|
US9428736B2
(en)
|
2010-09-02 |
2016-08-30 |
Mayo Foundation For Medical Education And Research |
Vesicular stomatitis viruses
|
|
US9623096B2
(en)
|
2011-11-09 |
2017-04-18 |
Celverum Inc. |
Virally infected hematopoietic cells and uses thereof
|
